HEADER VIRAL PROTEIN 07-NOV-14 4D5R TITLE STRUCTURE OF N-TERMINALLY TRUNCATED A49 FROM VACCINIA VIRUS WESTERN TITLE 2 RESERVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: A49; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 13-162; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VACCINIA VIRUS; SOURCE 3 ORGANISM_TAXID: 696871; SOURCE 4 STRAIN: WESTERN RESERVE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA2 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: POPTNH KEYWDS VIRAL PROTEIN, POXVIRUS, B CELL LYMPHOMA 2 (BCL-2) FAMILY, INNATE KEYWDS 2 IMMUNE MODULATOR, NUCLEAR FACTOR KAPPA B (NF-KB) EXPDTA X-RAY DIFFRACTION AUTHOR S.NEIDEL,C.MALUQUER DE MOTES,D.S.MANSUR,P.STRNADOVA,G.L.SMITH, AUTHOR 2 S.C.GRAHAM REVDAT 5 08-MAY-19 4D5R 1 REMARK REVDAT 4 25-MAR-15 4D5R 1 JRNL REVDAT 3 04-FEB-15 4D5R 1 JRNL REVDAT 2 28-JAN-15 4D5R 1 JRNL REVDAT 1 21-JAN-15 4D5R 0 JRNL AUTH S.NEIDEL,C.MALUQUER DE MOTES,D.S.MANSUR,P.STRNADOVA, JRNL AUTH 2 G.L.SMITH,S.C.GRAHAM JRNL TITL VACCINIA VIRUS PROTEIN A49 IS AN UNEXPECTED MEMBER OF THE JRNL TITL 2 B-CELL LYMPHOMA (BCL)-2 PROTEIN FAMILY JRNL REF J.BIOL.CHEM. V. 290 5991 2015 JRNL REFN ISSN 0021-9258 JRNL PMID 25605733 JRNL DOI 10.1074/JBC.M114.624650 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1279 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1744 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2399 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.85000 REMARK 3 B22 (A**2) : 5.38000 REMARK 3 B33 (A**2) : -3.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.153 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.142 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.038 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.974 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2479 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2370 ; 0.007 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3373 ; 1.749 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5446 ; 1.239 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 308 ; 5.672 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 127 ;35.967 ;26.142 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 455 ;13.086 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;21.013 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 406 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2845 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 549 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1217 ; 3.548 ; 3.764 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1216 ; 3.545 ; 3.761 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1527 ; 4.527 ; 5.617 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1262 ; 4.518 ; 4.227 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 163 REMARK 3 ORIGIN FOR THE GROUP (A): -21.5310 1.8910 -7.3620 REMARK 3 T TENSOR REMARK 3 T11: 0.1194 T22: 0.3050 REMARK 3 T33: 0.0494 T12: -0.0612 REMARK 3 T13: -0.0400 T23: -0.0271 REMARK 3 L TENSOR REMARK 3 L11: 3.0710 L22: 2.3520 REMARK 3 L33: 1.8766 L12: -1.3311 REMARK 3 L13: 0.7121 L23: -0.3372 REMARK 3 S TENSOR REMARK 3 S11: 0.0230 S12: -0.1038 S13: 0.1817 REMARK 3 S21: 0.2722 S22: -0.0857 S23: -0.0774 REMARK 3 S31: -0.1297 S32: -0.2510 S33: 0.0627 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 17 B 163 REMARK 3 ORIGIN FOR THE GROUP (A): -2.7680 -13.3870 -27.6790 REMARK 3 T TENSOR REMARK 3 T11: 0.0377 T22: 0.3426 REMARK 3 T33: 0.1591 T12: 0.0487 REMARK 3 T13: -0.0564 T23: 0.0147 REMARK 3 L TENSOR REMARK 3 L11: 1.1774 L22: 2.5613 REMARK 3 L33: 5.4836 L12: 0.3853 REMARK 3 L13: 0.9513 L23: 2.0211 REMARK 3 S TENSOR REMARK 3 S11: 0.1024 S12: 0.2450 S13: -0.1493 REMARK 3 S21: 0.0718 S22: 0.1983 S23: -0.3739 REMARK 3 S31: 0.2306 S32: 0.5157 S33: -0.3007 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED. REMARK 4 REMARK 4 4D5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-NOV-14. REMARK 100 THE DEPOSITION ID IS D_1290062243. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : TOROIDAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25211 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 33.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 1.15000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: AUTOSHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN BY MIXING 2 UL REMARK 280 PROTEIN (20-21 MG/ML) WITH 2 UL RESERVOIR SOLUTION AND REMARK 280 EQUILIBRATING AT 20 C AGAINST 500 UL RESERVOIRS CONTAINING 1.3- REMARK 280 1.5 M SODIUM MALONATE PH 6.8, 1% (VOL/VOL) PEG 400 AND 4-10% REMARK 280 (VOL/VOL) GLYCEROL, THE BEST CRYSTALS BEING OBTAINED WHEN THE REMARK 280 RESERVOIR WAS OVERLAID WITH 100 UL OF A 1:1 MIXTURE OF PARAFFIN REMARK 280 AND SILICONE OIL (MOLECULAR DIMENSIONS). CRYSTALS WERE REMARK 280 CRYOPROTECTED BY BRIEF IMMERSION IN 2.1 M SODIUM MALONATE, 1% REMARK 280 (VOL/VOL) PEG 400 AND 5% (VOL/VOL) GLYCEROL., TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.37000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 12 REMARK 465 SER A 164 REMARK 465 LYS A 165 REMARK 465 HIS A 166 REMARK 465 HIS A 167 REMARK 465 HIS A 168 REMARK 465 HIS A 169 REMARK 465 HIS A 170 REMARK 465 HIS A 171 REMARK 465 MET B 12 REMARK 465 VAL B 13 REMARK 465 LEU B 14 REMARK 465 GLY B 15 REMARK 465 TYR B 16 REMARK 465 SER B 164 REMARK 465 LYS B 165 REMARK 465 HIS B 166 REMARK 465 HIS B 167 REMARK 465 HIS B 168 REMARK 465 HIS B 169 REMARK 465 HIS B 170 REMARK 465 HIS B 171 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 13 CG1 CG2 REMARK 470 LYS A 45 CG CD CE NZ REMARK 470 GLN A 74 CG CD OE1 NE2 REMARK 470 GLN B 74 CG CD OE1 NE2 REMARK 470 GLU B 80 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 139 O HOH A 2038 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 136 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ASP A 141 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 141 CB - CG - OD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 ARG B 136 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ASP B 141 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 141 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 18 -154.91 -106.10 REMARK 500 CYS A 53 51.11 74.67 REMARK 500 CYS A 53 47.71 77.53 REMARK 500 ASP A 73 43.63 37.29 REMARK 500 SER B 18 -167.61 -106.04 REMARK 500 CYS B 53 50.28 78.69 REMARK 500 ASP B 73 45.82 36.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D5S RELATED DB: PDB REMARK 900 STRUCTURE OF A49 FROM VACCINIA VIRUS WESTERN RESERVE REMARK 900 RELATED ID: 4D5T RELATED DB: PDB REMARK 900 STRUCTURE OF N-TERMINALLY TRUNCATED A49 FROM VACCINIA VIRUS WESTERN REMARK 900 RESERVE REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL 12 AMINO ACIDS REMOVED TO PROMOTE REMARK 999 CRYSTALLISATION, CARRIES C-TERMINAL GSKH6 PURIFICATION TAG DBREF 4D5R A 13 162 UNP P31037 A49R_VACCW 13 162 DBREF 4D5R B 13 162 UNP P31037 A49R_VACCW 13 162 SEQADV 4D5R MET A 12 UNP P31037 EXPRESSION TAG SEQADV 4D5R GLY A 163 UNP P31037 EXPRESSION TAG SEQADV 4D5R SER A 164 UNP P31037 EXPRESSION TAG SEQADV 4D5R LYS A 165 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 166 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 167 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 168 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 169 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 170 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS A 171 UNP P31037 EXPRESSION TAG SEQADV 4D5R MET B 12 UNP P31037 EXPRESSION TAG SEQADV 4D5R GLY B 163 UNP P31037 EXPRESSION TAG SEQADV 4D5R SER B 164 UNP P31037 EXPRESSION TAG SEQADV 4D5R LYS B 165 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 166 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 167 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 168 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 169 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 170 UNP P31037 EXPRESSION TAG SEQADV 4D5R HIS B 171 UNP P31037 EXPRESSION TAG SEQRES 1 A 160 MET VAL LEU GLY TYR VAL SER ASP MET HIS THR GLU LEU SEQRES 2 A 160 ALA SER ILE SER GLN LEU VAL ILE ALA LYS ILE GLU THR SEQRES 3 A 160 ILE ASP ASN ASP ILE LEU ASN LYS ASP ILE VAL ASN PHE SEQRES 4 A 160 ILE MET CYS ARG SER ASN LEU ASP ASN PRO PHE ILE SER SEQRES 5 A 160 PHE LEU ASP THR VAL TYR THR ILE ILE ASP GLN GLU ASN SEQRES 6 A 160 TYR GLN THR GLU LEU ILE ASN SER LEU ASP ASP ASN GLU SEQRES 7 A 160 ILE ILE ASP CYS ILE VAL ASN LYS PHE MET SER PHE TYR SEQRES 8 A 160 LYS ASP ASN LEU GLU ASN ILE VAL ASP ALA ILE ILE THR SEQRES 9 A 160 LEU LYS TYR ILE MET ASN ASN PRO ASP PHE LYS THR THR SEQRES 10 A 160 TYR ALA GLU VAL LEU GLY SER ARG ILE ALA ASP ILE ASP SEQRES 11 A 160 ILE LYS GLN VAL ILE ARG GLU ASN ILE LEU GLN LEU SER SEQRES 12 A 160 ASN ASP ILE ARG GLU ARG TYR LEU GLY SER LYS HIS HIS SEQRES 13 A 160 HIS HIS HIS HIS SEQRES 1 B 160 MET VAL LEU GLY TYR VAL SER ASP MET HIS THR GLU LEU SEQRES 2 B 160 ALA SER ILE SER GLN LEU VAL ILE ALA LYS ILE GLU THR SEQRES 3 B 160 ILE ASP ASN ASP ILE LEU ASN LYS ASP ILE VAL ASN PHE SEQRES 4 B 160 ILE MET CYS ARG SER ASN LEU ASP ASN PRO PHE ILE SER SEQRES 5 B 160 PHE LEU ASP THR VAL TYR THR ILE ILE ASP GLN GLU ASN SEQRES 6 B 160 TYR GLN THR GLU LEU ILE ASN SER LEU ASP ASP ASN GLU SEQRES 7 B 160 ILE ILE ASP CYS ILE VAL ASN LYS PHE MET SER PHE TYR SEQRES 8 B 160 LYS ASP ASN LEU GLU ASN ILE VAL ASP ALA ILE ILE THR SEQRES 9 B 160 LEU LYS TYR ILE MET ASN ASN PRO ASP PHE LYS THR THR SEQRES 10 B 160 TYR ALA GLU VAL LEU GLY SER ARG ILE ALA ASP ILE ASP SEQRES 11 B 160 ILE LYS GLN VAL ILE ARG GLU ASN ILE LEU GLN LEU SER SEQRES 12 B 160 ASN ASP ILE ARG GLU ARG TYR LEU GLY SER LYS HIS HIS SEQRES 13 B 160 HIS HIS HIS HIS FORMUL 3 HOH *85(H2 O) HELIX 1 1 ASP A 19 ILE A 35 1 17 HELIX 2 2 GLU A 36 ILE A 38 5 3 HELIX 3 3 ASP A 39 MET A 52 1 14 HELIX 4 4 ASN A 59 ASP A 73 1 15 HELIX 5 5 GLN A 74 SER A 84 1 11 HELIX 6 6 ASP A 86 SER A 100 1 15 HELIX 7 7 PHE A 101 LYS A 103 5 3 HELIX 8 8 ASN A 105 ASN A 121 1 17 HELIX 9 9 ASN A 122 ALA A 138 1 17 HELIX 10 10 ILE A 142 LEU A 162 1 21 HELIX 11 11 ASP B 19 ILE B 35 1 17 HELIX 12 12 GLU B 36 ILE B 38 5 3 HELIX 13 13 ASP B 39 MET B 52 1 14 HELIX 14 14 ASN B 59 ASP B 73 1 15 HELIX 15 15 GLN B 74 SER B 84 1 11 HELIX 16 16 ASP B 86 SER B 100 1 15 HELIX 17 17 PHE B 101 LYS B 103 5 3 HELIX 18 18 ASN B 105 ASN B 121 1 17 HELIX 19 19 ASN B 122 ALA B 138 1 17 HELIX 20 20 ILE B 142 LEU B 162 1 21 CRYST1 56.850 42.740 67.190 90.00 100.51 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017590 0.000000 0.003263 0.00000 SCALE2 0.000000 0.023397 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015137 0.00000